The Impact of Menthol Flavoring on Switching in Adult Menthol Smokers

Part of paid clinical trials in Kansas City, Missouri.

Sponsor
Nikki Nollen, PhD, MA
Study ID
NCT05555069
Status
Recruiting
Apply to this trial

Conditions

  • Smoking Reduction

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Menthol-flavored electronic cigarette — OTHER
    Participants will receive 12 weeks of menthol -flavored electronic cigarettes to aid in switching from combustible cigarettes. Participants will be instructed on proper use of the electronic cigarettes, educated about electronic cigarettes and participate in motivation enhancement and substituting electronic cigarettes for cigarettes.
  • Tobacco-flavored electronic cigarette — OTHER
    Participants will receive 12 weeks of tobacco-flavored electronic cigarettes to aid in switching from combustible cigarettes. Participants will be instructed on proper use of the electronic cigarettes, educated about electronic cigarettes and participate in motivation enhancement and substituting electronic cigarettes for cigarettes.

Study Details

This study will compare the efficacy of menthol-flavored versus tobacco-flavored 4th generation nicotine salt-based pod-system e-cigarettes in facilitating a switch from combustible cigarettes to e-cigarettes in adult menthol smokers.

Key Dates

Start date
Nov 8, 2022
Status verified
Jan 2026
Primary completion
Dec 31, 2026
Completion
Mar 31, 2027

Study Design

Enrollment
800 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Active Comparator: Menthol Flavor Electronic Cigarette
    400 adult cigarette smokers will receive 12 weeks of menthol-flavored electronic cigarettes.
  • Active Comparator: Tobacco Flavor Electronic Cigarette
    400 adult cigarette smokers will receive 12 weeks of tobacco-flavored electronic cigarettes.

Primary Outcome Measure

Number of participants who switch from cigarettes to electronic cigarettes at Week 12 [ Time Frame: Week 12 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Kansas Medical CenterKansas CityMissouri64130
Tricia Snow
[email protected]
816-398-8960

Find similar trials in Kansas City, MO

By research site
University of Kansas Medical Center· Kansas City, MO

Related Studies